A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer. The Swons Gynaecological Cancer Group.
about
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' GroupPhase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumorsCarboplatin in combination with epirubicin and cyclophosphamide in patients with advanced ovarian cancer. A phase II study.Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancerTranstympanic Ringer's lactate application in the prevention of cisplatinum-induced ototoxicity in a chinchilla animal model.Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group.Nanocarriers for delivery of platinum anticancer drugs.First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence.Taste alterations in cancer patients receiving chemotherapy: a neglected side effect?Quality of life in patients receiving treatment for gynecologic malignancies: special considerations for patient care.Dose intensity analysis in advanced ovarian cancer patients.A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.Selecting combinations of chemotherapeutic drugs to maximize dose intensity.Efficacy and safety of DoceAqualip in a patient with locally advanced cervical cancer: A case report.
P2860
Q31962966-9EFF36D5-23C1-42A5-9A4E-AB8D46BC066DQ33407219-7CEF95D6-8A61-4A7C-B44A-30AEC77B7533Q33488506-BFB7F43D-3E17-49A8-B63D-A8FEA012780CQ33489286-622476F0-07CA-4371-A299-BA526BCF348EQ33498302-141E82A7-479A-44DD-BCE5-BA57DEA4A382Q33629840-9AAC830B-B7D3-4D01-8C6E-462039A569FEQ33909830-FE5C8AD5-33B1-4C6C-8DB7-FE7354138B23Q34338695-FFFB5295-99D9-4896-BA76-EFCB8C47C6DFQ34954738-3D70C040-B465-4174-8640-0B2BF35B874DQ35584199-1E16C378-AEC1-4BA3-A3D8-F8EEB3E9EB55Q35648863-F1A5EB54-AF3B-4CA9-9A75-1591DDBA1CB3Q35975958-08E35CEC-DBC8-4E05-9549-E67E542A117AQ35977532-76D39C7E-E04C-4E41-8DFC-CC33C80DF6F7Q37151124-401DDF2D-9AEA-49E1-A4BC-AB1F0F588DF4Q49706844-8B32522B-6B36-4341-9E73-533FE2435ECF
P2860
A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer. The Swons Gynaecological Cancer Group.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
A comparison of the toxicity a ...... s Gynaecological Cancer Group.
@ast
A comparison of the toxicity a ...... s Gynaecological Cancer Group.
@en
type
label
A comparison of the toxicity a ...... s Gynaecological Cancer Group.
@ast
A comparison of the toxicity a ...... s Gynaecological Cancer Group.
@en
prefLabel
A comparison of the toxicity a ...... s Gynaecological Cancer Group.
@ast
A comparison of the toxicity a ...... s Gynaecological Cancer Group.
@en
P2093
P1433
P1476
A comparison of the toxicity a ...... s Gynaecological Cancer Group.
@en
P2093
P356
10.3109/02841868909111182
P577
1989-01-01T00:00:00Z